Aldo P. Maggioni

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 16 papers. Top paper: “Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction”.

Sacubitril–valsartan as a treatment for apparent resistant hypertension in patients with heart failure and preserved ejection fraction

European Heart Journal(2021)10.1093/eurheartj/ehab499

N/A

4.2DataRank · unranked

154 citations

Pardeep S. Jhund, Inder S. Anand, Hans‐Dirk Düngen, Carolyn S.P. Lam, Marty Lefkowitz +15 more

Survival After Invasive or Conservative Management of Stable Coronary Disease

Circulation(2022)10.1161/circulationaha.122.062714

N/A

3.4DataRank · unranked

148 citations

Rebecca Anthopolos, Harmony R. Reynolds, Sripal Bangalore, Yifan Xu, Sean M. O’Brien +73 more

Impact of Complete Revascularization in the ISCHEMIA Trial

Journal of the American College of Cardiology(2023)10.1016/j.jacc.2023.06.015

N/A

1.6DataRank · unranked

45 citations

Ziad A. Ali, Sean M. O’Brien, Grace L. Rhodes, Philippe Généreux, Sripal Bangalore +89 more

Impact of Chronic Obstructive Pulmonary Disease in Patients With Heart Failure With Preserved Ejection Fraction: Insights From PARAGON‐HF

Journal of the American Heart Association(2021)10.1161/jaha.121.021494

N/A

1.6DataRank · unranked

45 citations

Nathaniel M. Hawkins, Pardeep S. Jhund, Margaret M. Redfield, Muthiah Vaduganathan, Akshay S. Desai +14 more

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC

European Heart Journal(2012)10.1093/eurheartj/ehs104

N/A

1.3DataRank · unranked

6898 citations

J. J. V. McMurray, S. Adamopoulos, S. D. Anker, M. Bohm, V. Falk +103 more

Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial

Circulation Heart Failure(2023)10.1161/circheartfailure.122.010259

N/A

1.3DataRank · unranked

52 citations

Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis +10 more

Beta-Blocker Use and Outcomes in Patients with Heart Failure and Mildly Reduced and Preserved Ejection Fraction

European Journal of Heart Failure(2024)10.1002/ejhf.3383

N/A

0.590DataRank · unranked

18 citations

Alasdair D Henderson, Li Shen, Toru Kondo, Mingming Yang, Ross T. Campbell +17 more

Causes of cardiovascular and noncardiovascular death in the ISCHEMIA trial

American Heart Journal(2022)10.1016/j.ahj.2022.01.017

N/A

0.505DataRank · unranked

28 citations

Karen P. Alexander, Zhen Huang, Sean M. O’Brien, Bernard Chaitman, Gregg W. Stone +29 more

International Variation in Health Status Benefits in Patients Undergoing Initial Invasive Versus Conservative Management for Chronic Coronary Disease: Insights From the ISCHEMIA Trial

Circulation Cardiovascular Quality and Outcomes(2024)10.1161/circoutcomes.123.010534

N/A

0.208DataRank · unranked

3 citations

John A. Spertus, Dan Nguyen, Zhuxuan Fu, Philip G. Jones, Harmony R. Reynolds +18 more

Sacubitril/valsartan and quality of life assessed using the EuroQol Five-dimension Three-level questionnaire level sum score (EQ-5D-3L-LSS) in patients with HFrEF and HFmrEF/HFpEF

European Heart Journal - Cardiovascular Pharmacotherapy(2025)10.1093/ehjcvp/pvaf064

N/A

0.104DataRank · unranked

1 citations

Alasdair D Henderson, Inder S. Anand, Akshay S. Desai, Carolyn S.P. Lam, Aldo P. Maggioni +14 more

Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart).

PubMed(2025)10.1093/eurheartj/ehae724

N/A

0DataRank · unranked

15 citations

Asad Bhatty, Gorav Batra, Suleman Aktaa, Adam B. Smith, Jeremy Dwight +26 more

Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

The Lancet Diabetes & Endocrinology(2024)10.1016/s2213-8587(24)00040-8

N/A

0DataRank · unranked

143 citations

David Preiss, Lisa Blackwell, Jonathan Emberson, Enti Spata, Kelly Davies +95 more

Prospective ARNI vs. ACE inhibitor trial to DetermIne Superiority in reducing heart failure Events after Myocardial Infarction (PARADISE‐MI): design and baseline characteristics

European Journal of Heart Failure(2021)10.1002/ejhf.2191

N/A

0DataRank · unranked

109 citations

Brian Claggett, Marc A. Pfeffer, Christopher B. Granger, Lars Køber, Eldrin F. Lewis +20 more

Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.14428

N/A

0DataRank · unranked

17 citations

Matthew D. Neal, Lucy Z. Kornblith, Michelle N. Gong, Harmony R. Reynolds, Mary Cushman +72 more

Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials

American Heart Journal(2021)10.1016/j.ahj.2021.06.001

N/A

0DataRank · unranked

2 citations

Beth A. Davison, Christopher Edwards, Stefanie Senger, John R. Teerlink, Faı̈ez Zannad +10 more

Clinical Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction and With Reduced Ejection Fraction According to the Prognostic Nutritional Index: Findings From PARADIGM‐HF and PARAGON‐HF

Journal of the American Heart Association(2024)10.1161/jaha.124.037782

N/A

0DataRank · unranked

14 citations

Mingming Yang, Paolo Tolomeo, Toru Kondo, Li Shen, Pardeep S. Jhund +14 more